Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Network Comparison Type description Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2675 to 2724 of 8289 in total
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1338\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.12) (e2) (pdc-e2) (70 kda mitochondrial autoantigen of primary biliary cirrhosis) (pbc) (m2 antigen complex 70 kda subunit). [source:swissprot;acc:p10515]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.159\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.739\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02213\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
GALE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucose 4-epimerase (ec 5.1.3.2) (galactowaldenase) (udp- galactose 4-epimerase). [source:swissprot;acc:q14376]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.162\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
210.412\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02257\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1339\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CEPT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
choline/ethanolaminephosphotransferase. [source:refseq;acc:nm\_006090]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.57\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02213\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
NPC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.204\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.71\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02239\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1340\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SUV39H2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 2 (ec 2.1.1.43) (histone h3-k9 methyltransferase 2) (h3-k9-hmtase 2) (suppressor of variegation 3-9 homolog 2) (su(var)3-9 homolog 2). [source:swissprot;acc:q9h5i1]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
226.433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
231.491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02234\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TBC1D5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tbc1 domain family member 5. [source:swissprot;acc:q92609]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.458\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02213\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1341\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF2S1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 1 (eukaryotic translation initiation factor 2 alpha subunit) (eif-2-alpha) (eif- 2alpha) (eif-2a). [source:swissprot;acc:p05198]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
231.491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02234\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RECK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
reversion-inducing cysteine-rich protein with kazal motifs precursor (hreck) (suppressor of tumorigenicity 15) (st15). [source:swissprot;acc:o95980]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.632\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.57\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02213\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1342\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHPT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
choline phosphotransferase 1; cholinephosphotransferase 1 alpha; cholinephosphotransferase 1. [source:refseq;acc:nm\_020244]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
187.631\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.569\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SUV39H1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 1 (ec 2.1.1.43) (histone h3-k9 methyltransferase 1) (h3-k9-hmtase 1) (suppressor of variegation 3-9 homolog 1) (su(var)3-9 homolog 1). [source:swissprot;acc:o43463]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.433\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
231.491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02234\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1343\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC25A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
m-phase inducer phosphatase 1 (ec 3.1.3.48) (dual specificity phosphatase cdc25a). [source:swissprot;acc:p30304]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
258.558\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
252.916\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02231\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MAP1LC3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
153.029\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
156.416\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02213\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1344\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK2A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
204.058\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.639\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EXO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exonuclease 1 isoform b; rad2 nuclease family member, homolog of s. cerevisiae exonuclease 1. [source:refseq;acc:nm\_006027]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.772\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
221.594\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02224\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1345\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
esterase d (ec 3.1.1.1). [source:swissprot;acc:p10768]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.431\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.093\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02212\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
FANCL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phd finger protein 9. [source:refseq;acc:nm\_018062]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.772\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
221.594\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02224\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1346\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SOLH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small optic lobes homolog; small optic lobes, drosophila, homolog of. [source:refseq;acc:nm\_005632]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
VPS35\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vacuolar protein sorting 35 (vesicle protein sorting 35) (hvps35) (maternal-embryonic 3). [source:swissprot;acc:q96qk1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.165\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.812\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02212\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1347\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIAS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipoic acid synthetase, mitochondrial (lip-syn) (lipoate synthase) (hussy-01) (fragment). [source:swissprot;acc:o43766]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.961\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
209.517\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02223\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l24. [source:refseq;acc:nm\_024540]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.881\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02211\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1348\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPIF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase, mitochondrial precursor (ec 5.2.1.8) (ppiase) (rotamase) (cyclophilin f). [source:swissprot;acc:p30405]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
201.458\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.1\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 1 (zinc finger protein of the cerebellum 1). [source:swissprot;acc:q15915]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.832\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02215\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1349\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CPA5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase a5. [source:refseq;acc:nm\_080385]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.671\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.613\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0221\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 3 (zinc finger protein of the cerebellum 3). [source:swissprot;acc:o60481]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.572\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.841\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02212\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1350\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CCT8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex protein 1, theta subunit (tcp-1-theta) (cct-theta). [source:swissprot;acc:p50990]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.762\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.399\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.0221\vspace{3pt}}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 2 (zinc finger protein of the cerebellum 2). [source:swissprot;acc:o95409]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.574\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
213.847\vspace{3pt}}&\\\cline{1-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1351\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleobindin 2 precursor (dna-binding protein nefa). [source:swissprot;acc:p80303]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.431\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
216.104\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
PHB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
211.513\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
206.941\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02209\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1352\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
CPB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
carboxypeptidase b precursor (ec 3.4.17.2) (pancreas-specific protein) (pasp). [source:swissprot;acc:p15086]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
183.595\vspace{3pt}}&\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1353\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
FRK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
201.009\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.664\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
NDST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparin sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.-) (n- hsst) (n-heparin sulfate sulfotransferase) (glucosaminyl n- deacetylase/n-sulfotransferase). [source:swissprot;acc:p52849]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
228.409\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
223.475\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02208\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1354\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-deacetylase/n-sulfotransferase (heparan glucosaminyl) 3. [source:refseq;acc:nm\_004784]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
UBQLN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquilin 1 isoform 1. [source:refseq;acc:nm\_013438]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.158\vspace{3pt}}&\\\cline{1-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1355\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-deacetylase/n-sulfotransferase 4. [source:refseq;acc:nm\_022569]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
223.475\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RASA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras gtpase-activating protein 3 (gap1(ip4bp)) (ins p4-binding protein). [source:swissprot;acc:q14644]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.643\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
198.269\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02206\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1356\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ca2+-promoted ras inactivator; gtpase activating protein-like; calcium-promoted ras inactivator. [source:refseq;acc:nm\_006989]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
NDST1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.8) (n-hsst) (hsnst) ([heparan sulfate]-glucosamine n-sulfotransferase) (n-heparan sulfate sulfotransferase) (glucosaminyl n-deacetylase/n- sulfotransferase). [source:swissprot;acc:p52848]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
228.409\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
223.475\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02208\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1357\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC27\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cdc27hs (cell division cycle protein 27 homolog) (h-nuc). [source:swissprot;acc:p30260]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RASA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras gtpase-activating protein 2 (gap1m). [source:swissprot;acc:q15283]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.643\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
198.269\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.02206\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1358\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
RASAL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rasgap-activating-like protein 1. [source:swissprot;acc:o95294]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
USF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
upstream stimulatory factor 1 (major late transcription factor 1). [source:swissprot;acc:p22415]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.987\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
210.359\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.022\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1359\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTT2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
228.642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
223.726\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02197\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RASA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rasgap-activating-like protein 2. [source:swissprot;acc:o43374]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.643\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.269\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02206\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1360\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPIE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptidyl-prolyl cis-trans isomerase e (ec 5.2.1.8) (ppiase e) (rotamase e) (cyclophilin e) (cyclophilin 33). [source:swissprot;acc:q9unp9]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
201.201\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
196.865\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02203\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
TGFBR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tgf-beta receptor type i precursor (ec 2.7.1.37) (tgfr-1) (tgf-beta type i receptor) (serine/threonine-protein kinase receptor r4) (skr4) (activin receptor-like kinase 5) (alk-5). [source:swissprot;acc:p36897]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.805\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1361\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SFRS10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginine/serine-rich splicing factor 10 (transformer-2-beta) (htra2- beta) (transformer 2 protein homolog) (silica-induced protein 41) (ra301). [source:swissprot;acc:q15815]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.014\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02201\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
USF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
upstream stimulatory factor 2 (upstream transcription factor 2) (fos-interacting protein) (fip) (major late transcription factor 2). [source:swissprot;acc:q15853]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
210.354\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02195\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1362\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAOX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
228.644\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
223.736\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.02194\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RCAN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.714\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.329\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.022\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/